Allen Young, Ms
About Allen Young, Ms
Allen Young is a Senior Regulatory Associate at Mirati Therapeutics in San Diego, California, where he has worked since 2020. He has a background in regulatory affairs, having held various positions at companies including Sorrento Therapeutics and La Jolla Pharmaceutical Company.
Work at Mirati Therapeutics
Allen Young has been employed at Mirati Therapeutics as a Senior Regulatory Associate since 2020. In this role, he is responsible for regulatory submissions and compliance activities, contributing to the company's mission in the biotechnology sector. His tenure at Mirati Therapeutics spans four years, during which he has engaged in various projects aimed at advancing the development of innovative therapies.
Previous Experience in Regulatory Affairs
Prior to his current position, Allen Young worked at several organizations in the regulatory affairs field. He served as a Regulatory Affairs Associate at Sorrento Therapeutics, Inc. for nine months in 2019. He also held the position of Regulatory Affairs Specialist 3 at Xynomic Pharma from 2019 to 2020. His experience includes roles at La Jolla Pharmaceutical Company, where he worked in various capacities, including Regulatory Affairs Intern/Associate and Regulatory and Quality Specialist I.
Educational Background
Allen Young earned a Master of Science (MS) in Regulatory Science from Johns Hopkins University Advanced Academic Programs, completing his studies between 2019 and 2020. He also holds a Bachelor of Science (B.S.) degree in Bioengineering: Bioinformatics from UC San Diego, where he studied from 2012 to 2017. His educational background provides a strong foundation for his work in regulatory affairs.
Career Path in San Diego
Allen Young's career has primarily taken place in the Greater San Diego Area. He began his professional journey in 2016 as a Lease Administration and Rent Specialist at Realty Income Corporation. He transitioned to regulatory roles shortly after, gaining experience at La Jolla Pharmaceutical Company and subsequently at Sorrento Therapeutics and Xynomic Pharma. His career trajectory reflects a focused commitment to regulatory affairs within the biotechnology and pharmaceutical industries.